Tesamorelin 5mg
Tesamorelin is a synthetic peptide made in the laboratory a stabilized version of the natural signal that prompts the pituitary gland to release growth hormone.
Research groups order it to study GHRH-receptor pharmacology, growth hormone pulsatility and the GH/IGF-1 axis, and fat-cell lipolysis signalling in preclinical models. Supplied strictly for laboratory research use only.
What Is Tesamorelin?
Tesamorelin is a stabilized 44-amino-acid analogue of growth hormone releasing hormone (GHRH), offered as a lyophilized laboratory reference material for research use only. Its defining structural feature is a trans-3-hexenoyl modification at the N-terminal tyrosine, which resists DPP-4 cleavage and keeps the full-length sequence intact through longer experimental windows than native GHRH.
Functionally, it behaves as an agonist at the GHRH receptor, a class B1 G protein-coupled receptor concentrated on anterior pituitary somatotrophs. Investigators use it as a pharmacological tool to trigger and then characterise endogenous growth hormone release, tracking cyclic AMP signalling in cell systems and pulse architecture in preclinical models.
Because the molecule works upstream — through a receptor rather than by supplying growth hormone directly — it is frequently selected for studies of intact endocrine feedback, including somatostatin tone and IGF-1-mediated regulation of the axis.
